EA
Ed Arce HC Wainwright & Co. Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Travere Therapeutics
TVTX
$1.89B
| $21.15 | $30 |
42%
upside
| Buy | 2 months ago |
|
2 |
2
Arcturus Therapeutics
ARCT
$455M
| $16.76 | $60 |
258%
upside
| Buy | 4 months ago |
|
3 |
3
Akebia Therapeutics
AKBA
$801M
| $3.02 | $7.50 |
148%
upside
| Buy | 5 months ago |
|
4 |
IVA
4
Inventiva
IVA
$779M
| $5.60 | $13 |
132%
upside
| Buy | 5 months ago |
|
5 |
5
Cidara Therapeutics
CDTX
$1.65B
| $64.93 | $35 |
46%
downside
| Buy | 5 months ago |
|
6 |
6
Akero Therapeutics
AKRO
$3.52B
| $44.03 | $75 |
70%
upside
| Buy | 6 months ago |
|
7 |
7
89bio
ETNB
$1.28B
| $8.61 | $21 |
144%
upside
| Buy | 6 months ago |
|
8 |
8
Mirum Pharmaceuticals
MIRM
$3.73B
| $74.18 | $72 |
3%
downside
| Buy | 6 months ago |
|
9 |
9
Madrigal Pharmaceuticals
MDGL
$9.61B
| $431.21 | $405 |
6%
downside
| Buy | 6 months ago |
|
10 |
10
Ardelyx
ARDX
$1.58B
| $6.57 | $5.50 |
16%
downside
| Neutral | 6 months ago |
|
11 |
11
Ultragenyx Pharmaceutical
RARE
$3.01B
| $31.28 | $95 |
204%
upside
| Buy | 6 months ago |
|
12 |
12
Arbutus Biopharma
ABUS
$769M
| $4.01 | $5 |
25%
upside
| Buy | 7 months ago |
|
13 |
13
NewAmsterdam Pharma
NAMS
$2.89B
| $25.66 | $48 |
87%
upside
| Buy | 7 months ago |
|
14 |
14
Terns Pharmaceuticals
TERN
$618M
| $7.06 | $7.50 |
6%
upside
| Neutral | 9 months ago |
|
15 |
15
Aurinia Pharmaceuticals
AUPH
$1.65B
| $12.53 | $13 |
4%
upside
| Buy | 1 year ago |
|
16 |
16
Vera Therapeutics
VERA
$1.4B
| $21.90 | $25 |
14%
upside
| Buy | 1 year ago |
|